These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17824900)

  • 1. The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis.
    Münch C; Meyer R; Linke P; Meyer T; Ludolph AC; Haas J; Hemmer B
    Acta Neurol Scand; 2007 Oct; 116(4):231-4. PubMed ID: 17824900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS.
    Münch C; Sedlmeier R; Meyer T; Homberg V; Sperfeld AD; Kurt A; Prudlo J; Peraus G; Hanemann CO; Stumm G; Ludolph AC
    Neurology; 2004 Aug; 63(4):724-6. PubMed ID: 15326253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD.
    Münch C; Rosenbohm A; Sperfeld AD; Uttner I; Reske S; Krause BJ; Sedlmeier R; Meyer T; Hanemann CO; Stumm G; Ludolph AC
    Ann Neurol; 2005 Nov; 58(5):777-80. PubMed ID: 16240349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of DCTN1 genetic variability in neurodegeneration.
    Vilariño-Güell C; Wider C; Soto-Ortolaza AI; Cobb SA; Kachergus JM; Keeling BH; Dachsel JC; Hulihan MM; Dickson DW; Wszolek ZK; Uitti RJ; Graff-Radford NR; Boeve BF; Josephs KA; Miller B; Boylan KB; Gwinn K; Adler CH; Aasly JO; Hentati F; Destée A; Krygowska-Wajs A; Chartier-Harlin MC; Ross OA; Rademakers R; Farrer MJ
    Neurology; 2009 Jun; 72(23):2024-8. PubMed ID: 19506225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCTN1-related neurodegeneration: Perry syndrome and beyond.
    Konno T; Ross OA; Teive HAG; Sławek J; Dickson DW; Wszolek ZK
    Parkinsonism Relat Disord; 2017 Aug; 41():14-24. PubMed ID: 28625595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
    Benešová Y; Vašků A; Stourač P; Hladíková M; Fiala A; Bednařík J
    J Neuroimmunol; 2013 Feb; 255(1-2):92-6. PubMed ID: 23186557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of CCR5delta32 gene mutation with multiple sclerosis in Croatian and Slovenian patients.
    Ristić S; Lovrecić L; Starcević-Cizmarević N; Brajenović-Milić B; Jazbec SS; Barac-Latas V; Vejnović D; Sepcić J; Kapović M; Peterlin B
    Mult Scler; 2006 Jun; 12(3):360-2. PubMed ID: 16764352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCTN1 gene analysis in Chinese patients with sporadic amyotrophic lateral sclerosis.
    Liu X; Yang L; Tang L; Chen L; Liu X; Fan D
    PLoS One; 2017; 12(8):e0182572. PubMed ID: 28792508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymorphism in the repetitive (TGGA)n sequence 5' to the human myelin basic protein gene in Italian multiple sclerosis patients.
    Guerini FR; Losciale L; Mediati M; Speciale L; Mancuso R; Saresella M; Calvo MG; Caputo D; Ferrante P
    J Neurovirol; 2000 May; 6 Suppl 2():S28-32. PubMed ID: 10871781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
    Camiña-Tato M; Fernández M; Morcillo-Suárez C; Navarro A; Julià E; Edo MC; Montalban X; Comabella M
    J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of apoptosis-related genes: Fas (CD94), FasL (CD178) and TRAIL polymorphisms in Iranian multiple sclerosis patients.
    Mohammadzadeh A; Pourfathollah AA; Sahraian MA; Behmanesh M; Daneshmandi S; Moeinfar Z; Heidari M
    J Neurol Sci; 2012 Jan; 312(1-2):166-9. PubMed ID: 21864851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy.
    Araki E; Tsuboi Y; Daechsel J; Milnerwood A; Vilarino-Guell C; Fujii N; Mishima T; Oka T; Hara H; Fukae J; Farrer MJ
    Mov Disord; 2014 Aug; 29(9):1201-4. PubMed ID: 24676999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.
    Comabella M; Altet L; Peris F; Villoslada P; Sánchez A; Montalban X
    Mult Scler; 2004 Dec; 10(6):618-20. PubMed ID: 15584484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
    Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
    Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes.
    Stockmann M; Meyer-Ohlendorf M; Achberger K; Putz S; Demestre M; Yin H; Hendrich C; Linta L; Heinrich J; Brunner C; Proepper C; Kuh GF; Baumann B; Langer T; Schwalenstöcker B; Braunstein KE; von Arnim C; Schneuwly S; Meyer T; Wong PC; Boeckers TM; Ludolph AC; Liebau S
    J Neural Transm (Vienna); 2013 May; 120(5):785-98. PubMed ID: 23143281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
    Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
    Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
    Stojković L; Djurić T; Stanković A; Dinčić E; Stančić O; Veljković N; Alavantić D; Zivković M
    J Neuroimmunol; 2012 Apr; 245(1-2):87-92. PubMed ID: 22261545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes.
    Caroppo P; Le Ber I; Clot F; Rivaud-Péchoux S; Camuzat A; De Septenville A; Boutoleau-Bretonnière C; Mourlon V; Sauvée M; Lebouvier T; Bonnet AM; Levy R; Vercelletto M; Brice A;
    JAMA Neurol; 2014 Feb; 71(2):208-15. PubMed ID: 24343258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.
    Myhr KM; Vågnes KS; Marøy TH; Aarseth JH; Nyland HI; Vedeler CA
    J Neurol Sci; 2002 Oct; 202(1-2):93-7. PubMed ID: 12220699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.